tiprankstipranks
Advertisement
Advertisement

ABCL Stock Latest News

AbCellera initiated with an Overweight at Cantor Fitzgerald
The FlyAbCellera initiated with an Overweight at Cantor Fitzgerald
16h ago
ABCL
AbCellera: Strategic Pivot to an Internal Pipeline and Key ABCL635 Readouts Position Shares for Multibillion-Dollar Upside
PremiumRatings
AbCellera: Strategic Pivot to an Internal Pipeline and Key ABCL635 Readouts Position Shares for Multibillion-Dollar Upside
13d ago
ABCL
AbCellera target is profile more attractive than Vistagen, says JonesResearch
PremiumThe Fly
AbCellera target is profile more attractive than Vistagen, says JonesResearch
13d ago
ABCL
VTGN
AbCellera: De-Risked Antibody Platform With High-Value Menopause Lead and Underappreciated Pipeline Optionality Supporting Buy Rating
PremiumRatings
AbCellera: De-Risked Antibody Platform With High-Value Menopause Lead and Underappreciated Pipeline Optionality Supporting Buy Rating
26d ago
ABCL
AbCellera initiated with a Buy at JonesResearch
PremiumThe Fly
AbCellera initiated with a Buy at JonesResearch
26d ago
ABCL
Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks
PremiumCompany AnnouncementsAbcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks
2M ago
ABCL
AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts
Premium
Company Announcements
AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts
2M ago
ABCL
AbCellera reports FY25 EPS (49c) vs. (55c) last year
Premium
The Fly
AbCellera reports FY25 EPS (49c) vs. (55c) last year
2M ago
ABCL
Is ABCL a Buy, Before Earnings?
PremiumPre-Earnings
Is ABCL a Buy, Before Earnings?
2M ago
ABCL
AbCellera doses first patients in Phase 2 portion of ABCL635 trial
PremiumThe Fly
AbCellera doses first patients in Phase 2 portion of ABCL635 trial
4M ago
ABCL
Viking Therapeutics names Neil Aubuchon as Chief Commercial Officer
PremiumThe Fly
Viking Therapeutics names Neil Aubuchon as Chief Commercial Officer
4M ago
ABCL
VKTX
AbCellera Secures Global Settlement and Patent License Deal
PremiumCompany Announcements
AbCellera Secures Global Settlement and Patent License Deal
5M ago
8K
ABCL
AbCellera to receive $36M upfront in patent litigation settlement with Bruker
PremiumThe FlyAbCellera to receive $36M upfront in patent litigation settlement with Bruker
5M ago
ABCL
BRKR
Strategic Shift and Promising Antibody Therapeutics Drive Buy Rating for AbCellera Biologics
Premium
Ratings
Strategic Shift and Promising Antibody Therapeutics Drive Buy Rating for AbCellera Biologics
6M ago
ABCL
AbCellera Appoints Dr. Stephen Quake to Board
Premium
Company Announcements
AbCellera Appoints Dr. Stephen Quake to Board
6M ago
8K
ABCL
AbCellera Biologics’ Earnings Call: Key Insights
PremiumCompany Announcements
AbCellera Biologics’ Earnings Call: Key Insights
6M ago
ABCL
3 Best Stocks to Buy Now, 11/7/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 11/7/2025, According to Top Analysts
6M ago
ABCL
BLND
AbCellera downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
AbCellera downgraded to Market Perform from Outperform at Leerink
6M ago
ABCL
AbCellera Biologics Reports Q3 2025 Financial Results
PremiumCompany Announcements
AbCellera Biologics Reports Q3 2025 Financial Results
6M ago
ABCL
AbCellera Biologics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsAbCellera Biologics Reports Q3 2025 Financial Results
6M ago
8K
ABCL
AbCellera reports Q3 EPS (19c), consensus (16c)
Premium
The Fly
AbCellera reports Q3 EPS (19c), consensus (16c)
6M ago
ABCL
AbCellera’s ABCL635 Study: A Promising Step for Menopause Treatment
Premium
Company Announcements
AbCellera’s ABCL635 Study: A Promising Step for Menopause Treatment
6M ago
ABCL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >